Loading stock data…
Electromed (ELMD)
$42.23+0.77 (+1.86%)
Market ClosedLast close Jun 29
Electromed, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Electromed, Inc. in the Healthcare sector is trading at $42.23 with a market capitalization of $308M. Wall Street consensus targets $40.33 (3 analysts), implying a -4.5% move over the next 12 months. The stock is currently near its 52-week high of $43.05, remaining 52.1% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $18.57M↓ | $18.90M↑ | $16.89M↓ | $17.39M↑ | $15.68M |
| Gross Profit | $14.64M↓ | $14.82M↑ | $13.20M↓ | $13.62M↑ | $12.23M |
| Operating Income | $3.77M↑ | $3.62M↑ | $2.67M↓ | $3.04M↑ | $2.14M |
| Net Income | $3.00M↑ | $2.76M↑ | $2.14M↓ | $2.20M↑ | $1.89M |
Peer Comparison
JNJUNHPFE
Fundamentals
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The co...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$307.94M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
20.55%
Volume
Today's trading volume
87,797
Recent News
ELV Accelerates Clinical Reviews Through Health OS Platform
Elevance Health's Health OS is cutting review delays and admin work, with early results showing fewer denials and holds as digital healthcare adoption expands.
Here's Why Momentum in Electromed (ELMD) Should Keep going
If you are looking for stocks that are well positioned to maintain their recent uptrend, Electromed (ELMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Is Electromed (ELMD) a Solid Growth Stock? 3 Reasons to Think "Yes"
Electromed (ELMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Best Momentum Stocks to Buy for June 2nd
GOLD, ELMD and TPR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 2nd, 2026.
New Strong Buy Stocks for June 2nd
GOLD, ELMD, TPR, PLGO and CRGY have been added to the Zacks Rank #1 (Strong Buy) List on June 2nd, 2026.